Most available drugs are effective for symptom control and structural protection, but they’re not perfect and new agents are being investigated to help close the treatment gap.
After rolling credits on Mina the Hollower, I did something unusual for me and immediately started a new file. I’m not ...
Discover hidden iPhone features for messages, photos, accessibility, privacy, call screening, and battery life that make iOS ...
A small clinical trial led by Dana-Farber Cancer Institute researchers has put a Salk Institute idea to the test in patients: ...
ASCO 2026 cancer breakthroughs from Chicago include daraxonrasib nearly doubling survival in metastatic pancreatic cancer, ...
Researchers added paricalcitol to chemotherapy and assessed outcomes in metastatic pancreatic cancer. The treatment remodeled ...
Morning Overview on MSN
Daraxonrasib, a daily RAS-blocking pill, raised pancreatic cancer survival from 6.7 to 13.2 months with fewer severe side effects than chemo
Patients with metastatic pancreatic cancer who had already failed at least one round of chemotherapy lived roughly twice as ...
Nootropics, often called brain boosters or smart supplements, are widely used to support focus, memory and mental performance. While some supplements show promise, nootropics tend to be more ...
Let’s break down the buzz and find out what the science (and the experts) actually say. Before diving into supplements that may (or may not) help extend the life of your injectable, it’s helpful to ...
Discusses Clinical Updates on Bezisterim and BIV201 for Parkinson's, Alzheimer's, and Ascites June 2, 2026 4:15 PM ...
15don MSN
GLP-1 Users May Experience A Surprising Life-Saving Benefit That Has Nothing To Do With Weight Loss
A new study found that some cancer patients who took GLP-1 drugs saw some remission — especially if they had breast cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results